Aldesleukin Unknown Status Phase 2 Trials for Renal Cancers Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00003664Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically
NCT00003604Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery
NCT00003181Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer
NCT00002589Lymphocyte Therapy in Treating Patients With Kidney Cancer
NCT00002846Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer
NCT00002847Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
NCT00005038Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer
NCT00080977High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2
NCT00301990Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer